{"id":"https://openalex.org/W4200292575","doi":"https://doi.org/10.3389/fonc.2021.788635","title":"A Retrospective Study of Lenvatinib Monotherapy or Combined With Programmed Cell Death Protein 1 Antibody in the Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma in China","display_name":"A Retrospective Study of Lenvatinib Monotherapy or Combined With Programmed Cell Death Protein 1 Antibody in the Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma in China","alternate_titles":[],"publication_year":2021,"publication_date":"2021-12-17","ids":{"openalex":"https://openalex.org/W4200292575","doi":"https://doi.org/10.3389/fonc.2021.788635","pmid":"https://pubmed.ncbi.nlm.nih.gov/34976828","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8718677"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2021.788635","doi":"https://doi.org/10.3389/fonc.2021.788635","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2021.788635","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4200292575"],"child_works_count":2,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fonc.2021.788635","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079999679","display_name":"Sihui Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111013","display_name":"Nanjing Drum Tower Hospital","ror":"https://ror.org/026axqv54","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210111013"]},{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]},{"id":"https://openalex.org/I881766915","display_name":"Nanjing University","ror":"https://ror.org/01rxvg760","country_code":"CN","type":"education","lineage":["https://openalex.org/I881766915"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Sihui Zhu","raw_affiliation_strings":["Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China","Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China","institution_ids":["https://openalex.org/I4210111013","https://openalex.org/I881766915"]},{"raw_affiliation_string":"Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China","institution_ids":["https://openalex.org/I4210111013","https://openalex.org/I83519826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100387419","display_name":"Chenxi Liu","orcid":"https://orcid.org/0000-0001-7154-1021","observed_orcids":["https://orcid.org/0000-0001-7154-1021"]},"institutions":[{"id":"https://openalex.org/I4210111013","display_name":"Nanjing Drum Tower Hospital","ror":"https://ror.org/026axqv54","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210111013"]},{"id":"https://openalex.org/I881766915","display_name":"Nanjing University","ror":"https://ror.org/01rxvg760","country_code":"CN","type":"education","lineage":["https://openalex.org/I881766915"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chenxi Liu","raw_affiliation_strings":["Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China","institution_ids":["https://openalex.org/I4210111013","https://openalex.org/I881766915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037328297","display_name":"Yanbing Dong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111013","display_name":"Nanjing Drum Tower Hospital","ror":"https://ror.org/026axqv54","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210111013"]},{"id":"https://openalex.org/I881766915","display_name":"Nanjing University","ror":"https://ror.org/01rxvg760","country_code":"CN","type":"education","lineage":["https://openalex.org/I881766915"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yanbing Dong","raw_affiliation_strings":["Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China","institution_ids":["https://openalex.org/I4210111013","https://openalex.org/I881766915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101702520","display_name":"Jie Shao","orcid":"https://orcid.org/0000-0002-4884-462X","observed_orcids":["https://orcid.org/0000-0002-4884-462X"]},"institutions":[{"id":"https://openalex.org/I4210111013","display_name":"Nanjing Drum Tower Hospital","ror":"https://ror.org/026axqv54","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210111013"]},{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]},{"id":"https://openalex.org/I881766915","display_name":"Nanjing University","ror":"https://ror.org/01rxvg760","country_code":"CN","type":"education","lineage":["https://openalex.org/I881766915"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jie Shao","raw_affiliation_strings":["Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China","Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China","institution_ids":["https://openalex.org/I4210111013","https://openalex.org/I881766915"]},{"raw_affiliation_string":"Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China","institution_ids":["https://openalex.org/I4210111013","https://openalex.org/I83519826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004716187","display_name":"Baorui Liu","orcid":"https://orcid.org/0000-0002-2539-7732","observed_orcids":["https://orcid.org/0000-0002-2539-7732"]},"institutions":[{"id":"https://openalex.org/I4210111013","display_name":"Nanjing Drum Tower Hospital","ror":"https://ror.org/026axqv54","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210111013"]},{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]},{"id":"https://openalex.org/I881766915","display_name":"Nanjing University","ror":"https://ror.org/01rxvg760","country_code":"CN","type":"education","lineage":["https://openalex.org/I881766915"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Baorui Liu","raw_affiliation_strings":["Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China","Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China","institution_ids":["https://openalex.org/I4210111013","https://openalex.org/I881766915"]},{"raw_affiliation_string":"Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China","institution_ids":["https://openalex.org/I4210111013","https://openalex.org/I83519826"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100411324","display_name":"Jie Shen","orcid":"https://orcid.org/0009-0003-6802-4252","observed_orcids":["https://orcid.org/0009-0003-6802-4252","https://orcid.org/0000-0001-7236-2068"]},"institutions":[{"id":"https://openalex.org/I4210111013","display_name":"Nanjing Drum Tower Hospital","ror":"https://ror.org/026axqv54","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210111013"]},{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]},{"id":"https://openalex.org/I881766915","display_name":"Nanjing University","ror":"https://ror.org/01rxvg760","country_code":"CN","type":"education","lineage":["https://openalex.org/I881766915"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jie Shen","raw_affiliation_strings":["Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China","Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China","institution_ids":["https://openalex.org/I4210111013","https://openalex.org/I881766915"]},{"raw_affiliation_string":"Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China","institution_ids":["https://openalex.org/I4210111013","https://openalex.org/I83519826"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5004716187","https://openalex.org/A5100411324"],"corresponding_institution_ids":["https://openalex.org/I4210111013","https://openalex.org/I83519826","https://openalex.org/I881766915"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":1.24,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.76874286,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"11","issue":null,"first_page":"788635","last_page":"788635"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lenvatinib","display_name":"lenvatinib","score":1.0},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.8109999895095825},{"id":"https://openalex.org/keywords/intrahepatic-cholangiocarcinoma","display_name":"intrahepatic cholangiocarcinoma","score":1.0},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.8519999980926514},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5879999995231628},{"id":"https://openalex.org/keywords/unresectable-liver-cancer","display_name":"unresectable liver cancer","score":0.8989999890327454},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8410000205039978},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.824999988079071},{"id":"https://openalex.org/keywords/chinese-patients","display_name":"Chinese patients","score":0.5839999914169312}],"concepts":[{"id":"https://openalex.org/C2776264508","wikidata":"https://www.wikidata.org/wiki/Q6523413","display_name":"Lenvatinib","level":4,"score":0.9927495718002319},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8728129863739014},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.7527999877929688},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6863347291946411},{"id":"https://openalex.org/C2909135397","wikidata":"https://www.wikidata.org/wiki/Q124292","display_name":"Intrahepatic Cholangiocarcinoma","level":2,"score":0.595443606376648},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5401659607887268},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.507658839225769},{"id":"https://openalex.org/C2776231280","wikidata":"https://www.wikidata.org/wiki/Q623031","display_name":"Liver cancer","level":3,"score":0.4472556412220001},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.4261270761489868},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.4113004505634308},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38258445262908936},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.11444437503814697}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2021.788635","doi":"https://doi.org/10.3389/fonc.2021.788635","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2021.788635","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8718677","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8718677/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8718677/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:34976828","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34976828","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:28ae4a8636834a74ad65bceea0ff52bb","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/28ae4a8636834a74ad65bceea0ff52bb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 11 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2021.788635","doi":"https://doi.org/10.3389/fonc.2021.788635","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2021.788635","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G3868364089","display_name":null,"funder_award_id":"No. QNRC2016043","funder_id":"https://openalex.org/F4320327778","funder_display_name":"Jiangsu Provincial Medical Youth Talent"},{"id":"https://openalex.org/G7087166190","display_name":null,"funder_award_id":"81902914","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320327778","display_name":"Jiangsu Provincial Medical Youth Talent","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200292575.pdf","grobid_xml":"https://content.openalex.org/works/W4200292575.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1968896691","https://openalex.org/W1971837077","https://openalex.org/W1990095055","https://openalex.org/W2013099235","https://openalex.org/W2025890159","https://openalex.org/W2122639773","https://openalex.org/W2140765540","https://openalex.org/W2151600653","https://openalex.org/W2787358630","https://openalex.org/W2796643083","https://openalex.org/W2805592007","https://openalex.org/W2969802526","https://openalex.org/W2969846817","https://openalex.org/W2992211060","https://openalex.org/W3031297691","https://openalex.org/W3045387409","https://openalex.org/W3098108849","https://openalex.org/W3121032265","https://openalex.org/W3122656440","https://openalex.org/W3137254944","https://openalex.org/W3146059045","https://openalex.org/W3147142721","https://openalex.org/W3164203228","https://openalex.org/W3199298180","https://openalex.org/W3206519712","https://openalex.org/W4210774372"],"related_works":["https://openalex.org/W4283793022","https://openalex.org/W4282000884","https://openalex.org/W4319459456","https://openalex.org/W4320856995","https://openalex.org/W4313041017","https://openalex.org/W3199298180","https://openalex.org/W3171160888","https://openalex.org/W3199745088","https://openalex.org/W3167367472","https://openalex.org/W4285210528"],"abstract_inverted_index":{"Lenvatinib":[0,26,84,128,151,180],"has":[1],"been":[2],"ratified":[3],"as":[4],"a":[5,32,92],"first-line":[6,74],"medication":[7],"for":[8,143],"advanced":[9],"liver":[10,41,190],"tumors":[11],"by":[12],"the":[13,21,28,130,163,175,182],"American":[14],"Food":[15],"and":[16,23,53,62,76,106,115,119,132,136,154,165,177],"Drug":[17],"Administration.":[18],"To":[19],"assess":[20],"effectiveness":[22],"security":[24,178],"of":[25,179,185],"in":[27,31,89,181],"Chinese":[29,186],"population":[30],"real-world":[33,183],"setting,":[34],"we":[35],"enrolled":[36],"48":[37],"patients":[38,57,69,125,159,187],"with":[39,91,127,147,150,188],"unresectable":[40,189],"cancer,":[42],"managed":[43,146],"from":[44],"December":[45],"2018":[46],"to":[47],"March":[48],"2021.":[49],"Among":[50],"them,":[51],"9":[52],"39":[54],"(83.30%":[55],"men)":[56],"had":[58,70,79],"intrahepatic":[59],"cholangiocarcinoma":[60],"(ICC)":[61],"hepatocellular":[63],"carcinoma":[64],"(HCC),":[65],"respectively.":[66,122,139,157],"Twenty-one":[67],"(43.75%)":[68],"progressive":[71],"disease":[72],"after":[73],"treatment,":[75],"others":[77],"(56.25%)":[78],"not":[80,161],"receiving":[81],"systemic":[82],"treatment.":[83],"was":[85,168],"administered":[86],"alone":[87],"or":[88],"combination":[90],"programmed":[93],"cell":[94],"death":[95],"protein":[96],"1":[97],"antibody":[98],"(anti-PD-1).":[99],"Treatment":[100],"duration,":[101],"median":[102,107],"progression-free":[103],"survival":[104,109],"(mPFS),":[105],"overall":[108],"(mOS)":[110],"were":[111,117,134,152],"examined.":[112],"The":[113,140,171],"mOS":[114,131,164],"mPFS":[116,133,167],"22.43":[118,135],"8.93":[120],"months,":[121,138,156],"Of":[123],"HCC":[124,144],"treated":[126],"only,":[129],"11.60":[137],"corresponding":[141],"values":[142],"cases":[145],"anti-PD-1":[148],"combined":[149],"21.77":[153],"7.10":[155],"ICC":[158],"did":[160],"reach":[162],"their":[166],"8.63":[169],"months.":[170],"present":[172],"findings":[173],"support":[174],"efficacy":[176],"therapy":[184],"cancer.":[191]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4200292575","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2021-12-31T00:00:00"}
